Tottenham Schedules Shareholder Vote on Clene Nanomedicine Merger

Tottenham Acquisition I set a Dec. 30 shareholder vote on its proposed merger with Clene Nanmedicine, a deal vlaued at $542.5 million. The preliminary proxy outlines terms of the deal and includes historical financial data on the merger target. Read more.

Total
0
Shares
Related Posts
Read More

Legacy Amends Warrant Agreement Ahead of Onyx Merger

The amendment calls for each of Legacy’s outstanding public warrants, and Legacy’s private placement warrants owned by certain institutional investors shall be converted into the right to receive an amount of cash and a number of shares of Class A common stock per warrant.